Home / What’s new? / Patents

Patents


Patent

Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer

Number
WO 2021/064142 A1
Year
2021
Customer
Tolremo
Site
Nijmegen
Department
Discovery
MCS People
Johan Veerman, Rutger Folmer, Martijn Eerland, Koen Hekking
Patent

Inhibitors of dual specificity tyrosine phosphorylation regulated kinase 1b

Number
WO 2021/064141 A1
Year
2021
Customer
Tolremo
Site
Nijmegen
Department
Discovery
MCS People
Koen Hekking, Rutger Folmer
Patent

Methods and intermediates for the preparation of bile acid derivatives

Number
US11066437B2
Year
2021
Customer
Intercept Pharmaceuticals
Site
Groningen
Department
Discovery
MCS People
Frederik Ronald Leusink, Bartjan Koning, Thomas Hensel
Patent

Progranulin Modulators and methods of using the same

Number
WO 2021/127303
Year
2021
Customer
Arkuda Therapeutics
Site
Department
Discovery
MCS People
Jean-Paul Seerden, Wim Zonneveld, Roel Bell
Patent

6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Number
WO 2020/089455 A1
Year
2020
Customer
AiCuris
Site
Nijmegen
Department
Discovery
MCS People
Jasper Springer
Patent

Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of cancer

Number
WO 2020/127200 A1
Year
2020
Customer
Tolremo
Site
Nijmegen
Department
Discovery
MCS People
Johan Veerman, Rutger Folmer
Patent

Inhibitors of vap-1

Number
WO 2020/069330, WO 2020/069335
Year
2020
Customer
Acucela
Site
Groningen
Department
Discovery
MCS People
Bas Dros, Eduardo Moreno, Jack den Hartog, Russell Craft and Hans Meissner
Patent

Isotopically-stabilized tetronimide compounds

Number
WO2020/168170 A1
Year
2020
Customer
Midwestern University
Site
Groningen
Department
Discovery
MCS People
Jean-Paul Seerden
Patent

Method for preparing 2-[(3r)-3-methylmorpholin-4-yl]-4-[1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-5-yl)-1,7-naphthyridine

Number
WO2020/039025 A1
Year
2020
Customer
Bayer Pharma
Site
Nijmegen
Department
Development
MCS People
Richard van der Haas, René Gieling, Sonja Hoogeveen, Matthijs van Oers, Jeroen Dekker
Patent

N-Arylsulfonyl amide compounds as NLRP3 inhibitors and their preparation

Number
WO 2019/166629 A1
Year
2020
Customer
Inflamazone
Site
Groningen
Department
Discovery
MCS People
Jim van Wiltenburg

* indicates required



 
 

Development Centres of Excellence Network Lead Optimization Hit Generation Lead Optimization
 
 
 
 
 

Development Centres of Excellence Network Lead Optimization Hit Generation Lead Optimization
 
 
 
Scroll to top